Microbiologic aspects of fluoroquinolones.
Fluoroquinolones are both old and new antimicrobial agents. The prototype agent of the class, nalidixic acid, was synthesized in 1962, whereas the new fluoroquinolones began to be used in the latter 1980s. During the past six years, orally administered fluoroquinolones have been used extensively in Japan and Europe to treat both community- and hospital-acquired infections. Most recently, one of the fluoroquinolones, ciprofloxacin, has also become available for parenteral and topical ophthalmic use. This article reviews the chemistry, antimicrobial activity, pharmacology, and clinical use of the fluoroquinolones.
Division of Infectious Diseases, College of Physicians & Surgeons of Columbia University, New York, N.Y.
H C
HC
Neu
D042462:4-Quinolones; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000890:Anti-Infective Agents / Q000009:adverse effects / Q000737:chemistry / Q000627:therapeutic use*; D004347:Drug Interactions; D004352:Drug Resistance, Microbial; D006801:Humans; D007239:Infections / Q000188:drug therapy
D042462:4-Quinolones; D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents